Old Second National Bank of Aurora’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-100
| Closed | -$18.4K | – | 284 |
|
|
2025
Q4 | $18.4K | Hold |
100
| – | – | ﹤0.01% | 235 |
|
|
2025
Q3 | $15.3K | Hold |
100
| – | – | ﹤0.01% | 242 |
|
|
2025
Q2 | $14K | Hold |
100
| – | – | ﹤0.01% | 246 |
|
|
2025
Q1 | $14.7K | Hold |
100
| – | – | ﹤0.01% | 256 |
|
|
2024
Q4 | $13.1K | Hold |
100
| – | – | ﹤0.01% | 276 |
|
|
2024
Q3 | $15.6K | Hold |
100
| – | – | ﹤0.01% | 271 |
|
|
2024
Q2 | $15.6K | Hold |
100
| – | – | ﹤0.01% | 262 |
|
|
2024
Q1 | $13.6K | Hold |
100
| – | – | ﹤0.01% | 263 |
|
|
2023
Q4 | $13.5K | Hold |
100
| – | – | ﹤0.01% | 270 |
|
|
2023
Q3 | $13.5K | Hold |
100
| – | – | ﹤0.01% | 262 |
|
|
2023
Q2 | $14.3K | Hold |
100
| – | – | ﹤0.01% | 268 |
|
|
2023
Q1 | $13.9K | Hold |
100
| – | – | ﹤0.01% | 278 |
|
|
2022
Q4 | $13.6K | Sell |
100
-50
| -33% | -$6.27K | ﹤0.01% | 274 |
|
|
2022
Q3 | $16K | Hold |
150
| – | – | ﹤0.01% | 259 |
|
|
2022
Q2 | $20K | Hold |
150
| – | – | 0.01% | 255 |
|
|
2022
Q1 | $20K | Buy |
150
+50
| +50% | +$6K | 0.01% | 261 |
|
|
2021
Q4 | $10K | Sell |
100
-50
| -33% | -$5.88K | ﹤0.01% | 272 |
|
|
2021
Q3 | $18K | Buy |
150
+50
| +50% | +$5.82K | ﹤0.01% | 262 |
|
|
2021
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 285 |
|
|
2021
Q1 | $10K | Hold |
100
| – | – | ﹤0.01% | 280 |
|
|
2020
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 269 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 280 |
|
|
2020
Q2 | $11K | Hold |
100
| – | – | ﹤0.01% | 283 |
|
|
2020
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 285 |
|
|
2019
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 308 |
|
|
2019
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 302 |
|
|
2019
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 323 |
|
|
2019
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 338 |
|
|
2018
Q4 | $8K | Hold |
100
| – | – | ﹤0.01% | 317 |
|
|
2018
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 325 |
|
|
2018
Q2 | $7K | Sell |
100
-78
| -44% | -$5.61K | ﹤0.01% | 330 |
|
|
2018
Q1 | $12K | Hold |
178
| – | – | ﹤0.01% | 290 |
|
|
2017
Q4 | $12K | Hold |
178
| – | – | ﹤0.01% | 296 |
|
|
2017
Q3 | $12K | Hold |
178
| – | – | 0.01% | 306 |
|
|
2017
Q2 | $12K | Hold |
178
| – | – | 0.01% | 285 |
|
|
2017
Q1 | $11K | Sell |
178
-255
| -59% | -$14.8K | ﹤0.01% | 281 |
|
|
2016
Q4 | $24K | Hold |
433
| – | – | 0.01% | 235 |
|
|
2016
Q3 | $28K | Hold |
433
| – | – | 0.01% | 205 |
|
|
2016
Q2 | $26K | Buy |
+433
| New | +$25.1K | 0.01% | 211 |
|
Other funds holding AZN
IA
Old Second National Bank of Aurora's AZN Position: Q1 2026 in Review
Old Second National Bank of Aurora sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 100 shares — an estimated $18.4K sold.
Old Second National Bank of Aurora first reported a position in AZN in Q2 2016 and held it in 39 quarters. The position peaked at $28K in Q3 2016. 1,385 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Old Second National Bank of Aurora reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Old Second National Bank of Aurora sold 100 AstraZeneca shares in Q1 2026, an estimated $18.4K.
- Old Second National Bank of Aurora first reported a position in AstraZeneca in Q2 2016 and held it in 39 quarters.
- Old Second National Bank of Aurora's AstraZeneca position peaked at $28K in Q3 2016.
- 1,385 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Old Second National Bank of Aurora's 13F filing for Q1 2026, filed 21 Apr 2026.